Citroniq Chemicals moved forward on its carbon-negative polypropylene strategy this week, combining a major offtake deal with heightened industry visibility. The private materials company focuses on OrganiqPP, a 100% biogenic, drop-in polypropylene aimed at helping customers cut Scope 3 emissions without changing existing processes.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Citroniq signed a 15-year binding offtake agreement with Premier Product Marketing, a Vinmar company, covering 50% of the planned capacity at its Nebraska plant. The facility is currently targeted to start production in 2029, and the long-term contract provides demand visibility that could support financing and project development.
Management emphasized that OrganiqPP is designed to integrate into packaging, consumer goods, automotive, and industrial supply chains as a low-carbon alternative to conventional polypropylene. The deal with Vinmar is viewed as early market validation for Citroniq’s technology and its positioning in the growing sustainable plastics and bioplastics segment.
Founder and CEO Kelly Knopp is also scheduled to speak at the World Chemical Forum in The Woodlands, Texas, in a session titled “Making Bio-Plastics the New Normal – A Sustainable Roadmap.” The presentation will highlight Citroniq’s vision to produce 100% biogenic, drop-in bio-polypropylene at world scale and to align with Net Zero emissions goals.
The company frames bio-based plastics as commercially ready and scalable, seeking to leverage regulatory and corporate decarbonization tailwinds that could favor low-carbon materials. Increased visibility at a major industry forum may help Citroniq build strategic relationships, validate its technical approach, and attract partners or capital providers across the chemicals and plastics value chain.
However, the Nebraska project’s 2029 start-up timeline underscores execution, technology scale-up, and market adoption risks that may affect the pace of future cash flow realization. Overall, the week marked a meaningful step in de-risking Citroniq’s first large-scale OrganiqPP project while reinforcing both the long-term opportunity and the challenges inherent in scaling bio-based plastics.

